Using advanced imaging to analyze kidney cancer tissues
Official title: Triboelectric Ambient Mass Spectrometry Imaging of Renal Cell Carcinomas
Funded at Georgia Institute of Technology · NIH-10932141 · Data updated 2026-11-12
This study is testing a new imaging method to better understand kidney cancer by looking closely at the molecules in tumor tissues, which could help doctors find better ways to diagnose and treat patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 20, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $190,557 |
| NIH project number | 5R61CA281667-02 |
| Project ID | NIH-10932141 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with clear cell renal carcinoma who are undergoing treatment or monitoring.
✕Less likely to help
Patients with other types of kidney cancer or those not diagnosed with renal cell carcinoma may not benefit from this research.
What this research studies
This research focuses on developing a new imaging technique called Triboelectric Ambient Mass Spectrometry Imaging (TENG MSI) to analyze the molecular composition of clear cell renal carcinoma tissues. By utilizing this innovative method, researchers aim to achieve higher sensitivity in detecting important lipids and metabolites that play a crucial role in kidney cancer. The study will benchmark the performance of TENG MSI against traditional imaging techniques to assess its effectiveness in providing detailed insights into cancer biology. Patients may benefit from improved diagnostic tools that can lead to better treatment strategies based on the molecular characteristics of their tumors.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnostics and personalized treatment options for patients with kidney cancer.
How similar studies have gone: Previous research has shown success with mass spectrometry imaging techniques, indicating potential for this novel approach to yield significant insights.
Where this research is happening
-
Georgia Institute of Technology
Atlanta, United States Active
Researchers
- Principal investigator: Fernandez, Facundo Martin — Georgia Institute of Technology
- Study coordinator: Fernandez, Facundo Martin
Related research
Other NIH-funded projects on the same topics.
-
Integrative AI tools to map protein sequences to structures and functions
A scientist team will develop advanced AI methods to better connect protein sequences, their 3D shapes, and how they work, using large biological data from sequencing and structures.
-
Robotic ultrasound-guided clot removal for stroke treatment
A new robot-assisted ultrasound system is being developed to help quickly reopen brain arteries during a stroke, with testing in patient-specific 3D-printed models and animal studies.
-
siRNA nanoparticle treatment to stop diabetic kidney damage
A new nanoparticle-delivered gene-silencing treatment aims to lower kidney inflammation in people with diabetes to help protect their kidneys.
-
Nanosensor blood test to spot early pancreatic cancer fingerprints
This project will use a nanosensor blood test to detect early-stage pancreatic cancer by reading a disease 'fingerprint' in patient serum.
-
Synergistic blood-brain barrier opening and targeted glioma treatment with pulsed electric fields
A new approach uses tiny, rapid electric pulses to safely disrupt the brain's protective barrier and enhance targeted treatment for malignant glioma.
-
Dexterous needle ablation for ventricular arrhythmia guided by MRI
A new MRI-guided, robot-assisted catheter delivers deeper heart tissue ablation to treat ventricular tachycardia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.